Know Cancer

or
forgot password

A Clinical Study to Limit Physiologic Intestinal FDG Uptake Uptake on PET-CT Scans


N/A
18 Years
N/A
Open (Enrolling)
Both
Intestinal FDG Uptake

Thank you

Trial Information

A Clinical Study to Limit Physiologic Intestinal FDG Uptake Uptake on PET-CT Scans


Inclusion Criteria:



- Patients undergoing clinically-indicated PET-CT scan for non-GI lymphoma

Exclusion Criteria:

- Patients with known Inflammatory Bowel Disease

- Patients with known colon cancer

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

SUVmax of FDG in each colonic segment

Outcome Time Frame:

Day 2

Safety Issue:

No

Authority:

United States: Food and Drug Administration

Study ID:

2010-P-000101

NCT ID:

NCT01542541

Start Date:

July 2011

Completion Date:

October 2012

Related Keywords:

  • Intestinal FDG Uptake

Name

Location

Beth Israel Deaconess Medical CenterBoston, Massachusetts  02215